1 Jul 2026
CBFβ–SMMHC in inv(16) AML: Fusion biology, RUNX1 dysregulation, and therapeutic targeting of a leukemogenic protein–protein interactionPublisher sitePathology - Research and Practice, Acute Myeloid Leukemia Research
Active, last published 2026
In chemotherapy-induced organ toxicity mitigation
Noha A.
Ahmed
Scholar“Research focused on Chemotherapy-induced organ toxicity mitigation and adjacent fields.”
Beni Suef University
Egypt
Claim Your ProfileEgypt10
H-index
338
Citations
Noha has not officially claimed their profile. If you are Noha, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
oha A. Ahmed is a researcher working on Chemotherapy-induced organ toxicity mitigation. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Noha's work has been cited 338 times across 3 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Chemotherapy-induced organ toxicity mitigation×4Drug-Induced Hepatotoxicity and Protection×3Pharmacological Effects of Natural Compounds×3Phytochemicals and Antioxidant Activities×2Mesenchymal stem cell research×2
04 · Where I am
Affiliations
Affiliation on published researchBeni-Suef University, EgyptDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
13 works26 May 2026
The CLOCK–BMAL1 complex in circadian regulation: structure, mechanisms, and therapeutic targetingPublisher siteInflammation Research, Circadian rhythm and melatonin
18 May 2026
Protein-protein interaction disruption as a next-generation antithrombotic strategyPublisher siteJournal of Thrombosis and Thrombolysis, Platelet Disorders and Treatments
16 May 2026Open access
Disrupting the CBFβ-SMMHC-RUNX1 oncogenic protein–protein interaction in inv(16) AML: from fusion biology to targeted therapyPublisher siteDiscover Oncology, Acute Myeloid Leukemia Research
1 May 2026
Targeting the Elongin <scp>BC</scp> – <scp>BC</scp> ‐Box Interface: Structural Insights, Peptidic Disruptors and Emerging Small‐Molecule StrategiesPublisher siteChemical Biology & Drug Design, Protein Degradation and Inhibitors
23 Apr 2026
From In Vitro Genotoxicity Assays to Human Biomarkers: Interpreting DNA Damage Signals in Long-Term SSRI Therapy through a Translational Neurotoxicology LensPublisher siteNeurotoxicity Research, Carcinogens and Genotoxicity Assessment
27 Sept 2024
Antioxidant Properties of Teucrium polium Extract Contribute to Neurochemical and Brain Structural Modulations in Nicotine-Induced MicePublisher siteCombinatorial Chemistry & High Throughput Screening, Phytochemistry and Biological Activities
1 Jan 20241cites
The use of tumor markers in prognosis of cancer and strategies to prevent cancer predisposition and progressPublisher siteElsevier eBooks, Nutrition, Genetics, and Disease
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Noha?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you